Katy Cooper

BSc, PhD (Sheffield)

Population Health, School of Medicine and Population Health

Senior Research Fellow and Director of Innovation

Katy Cooper
Profile picture of Katy Cooper
k.l.cooper@sheffield.ac.uk
+44 114 222 0773

Full contact details

Katy Cooper
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Profile

I joined ScHARR in 2004, and since 2007 I have worked in HEDS undertaking systematic reviews of clinical effectiveness of healthcare interventions. From 2004 to 2006 I worked on a number of projects relating to patient safety and quality of care. I gained my BSc and PhD in genetics and cell biology from the University of Sheffield.

Research interests
  • Systematic reviews of clinical effectiveness for healthcare interventions
  • Development of methods for systematic reviewing and evidence synthesis, including rapid review methods
  • Systematic reviews of complex interventions
  • Patient safety and quality of care
  • Complementary and alternative medicine research

Recent projects

  • I have recently worked on systematic reviews of the following:
  • Treatments for advance Parkinsons disease
  • Management of premature ejaculation
  • Psychosocial interrentions for cannabis cessation
  • Therapeutic effects of yoga for health and wellbeing
  • Prevalence of complementary and alternative medicine use
  • Comparison of triage and direct transfer to specialist care centres versus delivery to the nearest local hospital
  • Chemoprevention of colorectal cancer
  • PET and MRI imaging for assessment of axillary metastases in breast cancer
  • Romiplostim for idiopathic thrombocytopenic purpura
  • Homeopathy for insomnia
  • Vildagliptin for type 2 diabetes
  • Pegfilgrastim for prevention of febrile neutropenia during chemotherapy
  • Oseltamivir, zanamivir and amantadine for prevention of influenza
Publications

Show: Featured publications All publications

Journal articles

All publications

Journal articles

Conference proceedings papers

  • Kearns B, Cooper K, Orr M, Essat M, Hamilton J & Cantrell A (2022) ADVERSE EVENTS ASSOCIATED WITH ANTIDEPRESSANTS: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS. VALUE IN HEALTH, Vol. 25(1) (pp S25-S26) RIS download Bibtex download
  • Kearns B, Cooper K & Cantrell A (2020) SCHIZOPHRENIA TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS: A MULTI-COUNTRY EVALUATION OF THE COSTS OF CARDIOVASCULAR AND METABOLIC ADVERSE EVENTS AND WEIGHT GAIN. VALUE IN HEALTH, Vol. 23 (pp S605-S605) RIS download Bibtex download
  • Milevska-Kostova N, Cooper K & Cooper R () Nostalgia for the Past: Precsribing and Dispensing Practices in Macedionia. Nostalgia for the Past: Prescribing and Dispensing Practices in Macedonia RIS download Bibtex download

Website content

Posters

  • Kearns B, Cooper K, Orr M, Essat M, Hamilton J & Cantrell A (2022) POSB7 Adverse Events Associated with Antidepressants: A Systematic Literature Review and Network Meta-Analysis. RIS download Bibtex download

Other

Preprints

  • Cooper K, Essat M, Clowes M, Chilcott J, Hunter K & Bessey A (2022) Diagnostic accuracy of biopsy versus full excision for diagnosis of oral cancer: A systematic review. RIS download Bibtex download
Teaching interests

My teaching interests include systematic reviews and critical appraisal, meta-analysis, health research methods, and processes for health technology assessment. I teach on several ScHARR masters courses and short courses.

I am a module co-ordinator on the Methods and Processes module on the MSc in International Health Technology Assessment.

I am interested in supervising research students in areas such as systematic review methodology and reviews of complex interventions, complementary therapies and preventative interventions.

Professional activities and memberships

I am a member of the ScHARR Technology Assessment Group (ScHARR-TAG). I undertake high quality evidence syntheses for the National Institute for Health and care Excellence (NICE), the NIHR Health Technology Assessment Programme, and other funding organisations.